Green stability-indicating RP-HPTLC approach for determining suvorexant in commercial tablet dosage forms
Abstract A novel sedative/hypnotic drug called suvorexant (SUV) is advised for treating insomnia. From a forensic standpoint, it is important medicine because of its sedative/hypnotic and depressing effects. There are no green “high-performance thin-layer chromatographic (HPTLC)” techniques for meas...
Saved in:
| Main Authors: | Prawez Alam, Faiyaz Shakeel, Mohammed H. Alqarni, Ahmed I. Foudah, Tariq M. Aljarba, Fatma M. Abdel Bar, Mohd Imran, Mohammad Ali |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-02-01
|
| Series: | BMC Chemistry |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13065-025-01431-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Simultaneous quantification of mefenamic acid and paracetamol in fixed-dose combination tablet dosage forms using the green HPTLC method
by: Alam Prawez, et al.
Published: (2025-03-01) -
Suvorexant: a promising, novel treatment for insomnia
by: Lee-Iannotti J, et al.
Published: (2016-02-01) -
Characteristics of psychiatric patients with nightmares after suvorexant administration: A retrospective study
by: Kazuya Yasuda, et al.
Published: (2025-03-01) -
Development and validation of a RP–HPLC method for the quantization studies of metronidazole in tablets and powders dosage forms
by: Elena Gabriela Oltean,, et al.
Published: (2011-12-01) -
Quality by design driven RP-HPLC method optimization for analysis of levothyroxine and liothyronine in bulk and tablet dosage form
by: Ramdas Darade, et al.
Published: (2025-04-01)